Cable Hill Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Cable Hill Partners’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-245	Closed	-$14K	–	749
2016 Q1	$14K	Buy	245 +6	+3%	+$443	0.01%	302
2015 Q4	$27K	Hold	239	–	–	0.02%	196
2015 Q3	$29K	Sell	239 -6	-2%	-$784	0.02%	197
2015 Q2	$20K	Sell	245 -105	-30%	-$6.88K	0.02%	306
2015 Q1	$20K	Sell	350 -1	-0.3%	-$42	0.02%	295
2014 Q4	$11K	Buy	+351	New	+$10.5K	0.01%	423

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Cable Hill Partners's ANAC Position: Q2 2016 in Review

Cable Hill Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 245 shares — an estimated $14K sold.

Cable Hill Partners first reported a position in ANAC in Q4 2014 and held it in 6 quarters. The position peaked at $29K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Cable Hill Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Cable Hill Partners sold 245 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $14K.
Cable Hill Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 6 quarters.
Cable Hill Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $29K in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Cable Hill Partners's 13F filing for Q2 2016, filed 12 Aug 2016.